Qatar diabetes mobile application trial (qdmat): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus—a study protocol

HIGHLIGHTS

• who: Noor Suleiman from the Department of Medicine, Weill Cornell Medicine u2013 Qatar, Doha, Qatar York, USA have published the article: Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitusu2014a study protocol, in the Journal: (JOURNAL) of 26/06/2019
• what: The aim of the Qatar Diabetes Mobile Application Trial (QDMAT) is to examine the impact of including the Droobi app in diabetes care on diabetes outcomes compared to standard diabetes care. For the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.